Researchers from the universities of Zurich, Yale and Harvard reveal the differences between the characteristics of the ...
The latest health news covers the European Medicines Agency's approval of Novo Nordisk's Wegovy for heart conditions linked ...
Isatuximab (Sarclisa) with bortezomib, lenalidomide, and dexamethasone (VRd) is now an approved option for adults who cannot ...
The European Medicines Agency's (EMA's) Committee for Medicinal Products for Human Use (CHMP) recommended the granting of ...
The European Medicines Agency approved Afqlir and Opuviz to treat age-related macular degeneration while reiterating its ...
KONFIDENT phase 3 trial results demonstrated significantly faster symptom relief with sebetralstat compared to placebo.
The European Medicines Agency backed the use of Novo Nordisk's popular drug Wegovy to help ease heart failure in people with ...
Upon authorization by the European Commission, the Omicron KP.2-adapted COVID-19 vaccine will be available for individuals 6 months of age and ...
Dupixent recommended for EU approval by the CHMP to treat eosinophilic esophagitis in children as young as 1 year old Recommendation based on a ...
The European Commission on Friday extended the authorization of the Imvanex mpox vaccine to teenagers aged 12 to 17.
Elahere, which won initial U.S. Food and Drug Administration approval in 2022 for platinum-resistant ovarian cancer, was the key asset in AbbVie's $10.1 billion acquisition of biotech ImmunoGen that ...
Novo Nordisk's Wegovy label update receives a positive opinion from the EMA's CHMP, highlighting improvements in heart ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results